Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125740271 | 12574027 | 1 | I | 2016 | 20160713 | 20160720 | 20160720 | EXP | US-AMGEN-USASL2016091284 | AMGEN | 67.00 | YR | E | F | Y | 0.00000 | 20160720 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125740271 | 12574027 | 1 | PS | REPATHA | EVOLOCUMAB | 1 | Unknown | UNK UNK, Q2WK | Y | 1067507 | 125522 | SOLUTION FOR INJECTION | QOW | ||||||
| 125740271 | 12574027 | 2 | SS | REPATHA | EVOLOCUMAB | 1 | Y | 125522 | SOLUTION FOR INJECTION | ||||||||||
| 125740271 | 12574027 | 3 | SS | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 0 | |||||||||||
| 125740271 | 12574027 | 4 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 125740271 | 12574027 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125740271 | 12574027 | 1 | Hyperlipidaemia |
| 125740271 | 12574027 | 2 | Blood triglycerides increased |
| 125740271 | 12574027 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125740271 | 12574027 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125740271 | 12574027 | Breast cancer | |
| 125740271 | 12574027 | Fatigue | |
| 125740271 | 12574027 | Hypotension | |
| 125740271 | 12574027 | Injection site rash | |
| 125740271 | 12574027 | Macule | |
| 125740271 | 12574027 | Nausea | |
| 125740271 | 12574027 | Neuropathy peripheral | |
| 125740271 | 12574027 | Rash | |
| 125740271 | 12574027 | Skin discolouration | |
| 125740271 | 12574027 | Skin exfoliation | |
| 125740271 | 12574027 | Swelling | |
| 125740271 | 12574027 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125740271 | 12574027 | 1 | 201604 | 0 |